-
1 Comment
INBIOGEN CO.,Ltd is currently in a long term uptrend where the price is trading 0.5% above its 200 day moving average.
From a valuation standpoint, the stock is 985.7% more expensive than other stocks from the Consumer Cyclical sector with a price to sales ratio of 16.0.
INBIOGEN CO.,Ltd's total revenue sank by 6.4% to $2B since the same quarter in the previous year.
Its net income has dropped by 309.3% to $-32B since the same quarter in the previous year.
Finally, its free cash flow fell by 631.3% to $-4B since the same quarter in the previous year.
Based on the above factors, INBIOGEN CO.,Ltd gets an overall score of 1/5.
| Exchange | KO |
|---|---|
| CurrencyCode | KRW |
| ISIN | KR7101140002 |
| Industry | Footwear & Accessories |
| Sector | Consumer Cyclical |
| Market Cap | 70B |
|---|---|
| PE Ratio | None |
| Beta | 1.14 |
| Target Price | None |
| Dividend Yield | None |
INBIOGEN Co., Ltd. engages in the manufacture and distribution of footwear products in South Korea. It is also involved in distribution of wood pellets; kiosk; and food and beverage businesses. The company was formerly known as BTONE CO.,Ltd. INBIOGEN Co., Ltd. was founded in 1949 and is headquartered in Seoul, South Korea.
Learn MoreHere's how to backtest a trading strategy or backtest a portfolio for 101140.KO using our backtest tool. PyInvesting provides the backtesting software for you to backtest your investment strategy. Our backtest software is written using Python code and allows you to backtest stock, backtest etf, backtest options, backtest crypto and backtest forex online. Our backtesting Python framework is highly robust and gives you a realistic simulation of how your strategy would have performed in the past using backtest data.
© PyInvesting 2025
